Amicus Therapeutics Introduces Proprietary CHART Platform Technology

[at noodls] – New Platform Designation Reflects Development Strategy and Emphasis on Next-Generation Enzyme Replacement Therapies for Lysosomal Storage Diseases CRANBURY, N.J., March 4, 2013 (GLOBE NEWSWIRE) — Amicus … more

View todays social media effects on FOLD

View the latest stocks trending across Twitter. Click to view dashboard

See who Amicus is hiring next, click here to view